NPI: 1780943514 · NEWARK, NJ 07114 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 05/14/2012
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 05/14/2012 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 19,145 | $2.40M |
| 2019 | 14,365 | $1.52M |
| 2020 | 11,853 | $987K |
| 2021 | 11,259 | $699K |
| 2022 | 13,539 | $644K |
| 2023 | 5,833 | $228K |
| 2024 | 4,221 | $374K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 36,425 | 2,862 | $4.74M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 16,574 | 1,155 | $1.22M |
| J1270 | Injection, doxercalciferol, 1 mcg | 12,861 | 1,104 | $540K |
| J1756 | Injection, iron sucrose, 1 mg | 3,301 | 828 | $97K |
| A4657 | Syringe, with or without needle, each | 8,629 | 1,496 | $63K |
| 83550 | 341 | 333 | $39K | |
| 83540 | 341 | 333 | $39K | |
| 85041 | 279 | 273 | $33K | |
| 85048 | 280 | 274 | $33K | |
| 83970 | 205 | 204 | $27K | |
| 82728 | 176 | 175 | $19K | |
| G0008 | Administration of influenza virus vaccine | 109 | 92 | $923.03 |
| 90674 | 42 | 42 | $923.03 | |
| A4913 | Miscellaneous dialysis supplies, not otherwise specified | 22 | 12 | $737.97 |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 286 | 104 | $0.06 |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 42 | 23 | $0.00 |
| OP250 | 279 | 13 | $0.00 | |
| 82108 | 23 | 23 | $0.00 |